GOP Tax Reform Bill Would Repeal Orphan Drug Research Credits
By Zachary Brennan -
Published 02 November 2017
Republicans on Thursday rolled out their new tax reform bill, which among other provisions to lower taxes for Americans and businesses, proposes to repeal a provision that might cause the biopharma industry some concern.
Categories: News, US, FDA, Biologics and biotechnology, Clinical, Drugs
Tags: orphan drug tax credit, orphan drug research, BIO, Allergan